Furthermore, the HBV viral protein HBx affects UHRF2 phosphorylation by ectopic overexpression of HBx in HBV-negative HepG2 cells, suppressing DHX9 expression in HBV-positive HCC and promoting HBV disease progression (Fig. 5C–F). Here, DHX9 is linked to hepatocellular carcinoma.